Immunovant
Developing targeted autoimmune therapies
- B2B
About Immunovant
A clinical-stage immunology company developing targeted therapies for autoimmune diseases to improve the lives of affected individuals Visit immunovantcom for more information
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- new york, New York, United States
- Founded
- 2018
- Revenue
- $27.1M – $214MTamtam estimate
- Website
- immunovant.com
- linkedin.com/company/immunovant
Immunovant at a glance
Immunovant is a B2B company in the Biotechnology Research industry, headquartered in new york, New York, United States.
Immunovant was founded in 2018.
Immunovant has 251–1,000 employees.
Immunovant's revenue is $27.1M – $214M (Tamtam estimate).
Selling to companies like Immunovant?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies